The clinical implications of medulloblastoma subgroups (Q38008153)

26 August 2017

title

The clinical implications of medulloblastoma subgroups (English)

1 reference

26 August 2017

0 references

Stefan M Pfister

3

0 references

Paul A Northcott

series ordinal

1

object named as

Paul A Northcott

1 reference

26 August 2017

2

Andrey Korshunov

1 reference

26 August 2017

4

Michael D Taylor

1 reference

26 August 2017

language of work or name

English

0 references

publication date

8 May 2012

1 reference

26 August 2017

published in

Nature Reviews Neurology

1 reference

26 August 2017

volume

8

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

340-351

1 reference

Genomics of medulloblastoma: from Giemsa-banding to next-generation sequencing in 20 years

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Molecular pathogenesis of childhood brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Identification of differentially expressed and developmentally regulated genes in medulloblastoma using suppression subtraction hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Transcriptional profiling of medulloblastoma in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Molecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Medulloblastoma: present concepts of stratification into risk groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Childhood medulloblastoma: progress and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Quality of long-term survival in young children with medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Medulloblastoma in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Current treatment approaches to early childhood medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Treatment of early childhood medulloblastoma by postoperative chemotherapy alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Medulloblastoma incidence has not changed over time: a CBTRUS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Do children and adults differ in survival from medulloblastoma? A study from the SEER registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Biologic risk stratification of medulloblastoma: the real time is now.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

High-risk medulloblastoma: does c-myc amplification overrule histopathology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Central nervous system atypical teratoid rhabdoid tumours: the Canadian Paediatric Brain Tumour Consortium experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Embryonal tumor with abundant neuropil and true rosettes (ETANTR): a new distinctive variety of pediatric PNET: a case-based update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome--a new clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

c-myc overexpression causes anaplasia in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Prediction of central nervous system embryonal tumour outcome based on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Subtypes of medulloblastoma have distinct developmental origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Biological and clinical heterogeneity of MYCN-amplified medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Medulloblastoma comprises four distinct molecular variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Adult medulloblastoma comprises three major molecular variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Molecular subgroups of medulloblastoma: the current consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

The molecular basis of Turcot's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Role of Wnt pathway in medulloblastoma oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Altered Neural Cell Fates and Medulloblastoma in Mouse patched Mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Retrospective family study of childhood medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Mutations in SUFU predispose to medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Identification of a SUFU germline mutation in a family with Gorlin syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Medulloblastoma: a problem of developmental biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Normal and oncogenic roles for microRNAs in the developing brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Hedgehog and PI-3 kinase signaling converge on Nmyc1 to promote cell cycle progression in cerebellar neuronal precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Molecular diagnostics of CNS embryonal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Pleiotropic role for MYCN in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Multiplexed measurements of gene signatures in different analytes using the Nanostring nCounter Assay System

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Direct multiplexed measurement of gene expression with color-coded probe pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Expression of MAGE and GAGE genes in medulloblastoma and modulation of resistance to chemotherapy. Laboratory investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

PCDH10 is a candidate tumour suppressor gene in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

The genetic landscape of the childhood cancer medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Tuberous sclerosis complex suppression in cerebellar development and medulloblastoma: separate regulation of mammalian target of rapamycin activity and p27 Kip1 localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Clonal selection drives genetic divergence of metastatic medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Medulloblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Mouse models of medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

An animal model of MYC-driven medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

A mouse model of the most aggressive subgroup of human medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

The origins of medulloblastoma subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

The developmental biology of brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

International network of cancer genome projects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Childhood medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Embryonal tumor with abundant neuropil and true rosettes (ETANTR) with a focal amplification at chromosome 19q13.42 locus: Further evidence of two new instances in China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2012.78

31 March 2020

1 reference

12 December 2020

Medulloblastoma: presentation, diagnosis and management.

1 reference

12 December 2020

Management of children with primitive neuroectodermal tumors of the posterior fossa/medulloblastoma

1 reference

12 December 2020

Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system.

1 reference

12 December 2020

Pediatric brain tumors: a contemporary prospectus

1 reference

12 December 2020

Monosomy 22 in rhabdoid or atypical teratoid tumors of the brain

1 reference

12 December 2020

The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors

1 reference

12 December 2020

Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid

1 reference

12 December 2020

Sporadic medulloblastomas contain oncogenic beta-catenin mutations.

1 reference

12 December 2020

Genomic amplification of orthodenticle homologue 2 in medulloblastomas

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEUROL.2012.78

1 reference

Dimensions Publication ID

26 August 2017

1025875930

0 references

1 reference